СLINICAL AND IMMUNOLOGICAL EFFICIENCY OF IMUNOFAN AND POLYOXIDONIUM IN COMBINED THERAPY OF COMMUNITY-ACQUIRED PNEUMONIA

QR Code

СLINICAL AND IMMUNOLOGICAL EFFICIENCY OF IMUNOFAN AND POLYOXIDONIUM IN COMBINED THERAPY OF COMMUNITY-ACQUIRED PNEUMONIA

Abstract. A study was carried out in hundred-five patients with severe or mid-severe clinical courseof community-acquired pneumonia. Clinical observations showed that introduction of Imunofan andPolyoxidonium within combined therapeutic regimen administered to the patients, exerts a pronounced posit...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	L. R. Mukhamadieva, G. A. Mavzyutova, R. M. Fazlyeva, N. R. Bikhmetova
Format:	article
Langue:	RU
Publié:	SPb RAACI 2014
Sujets:	community-acquired pneumonia imunofan polyoxidonium Immunologic diseases. Allergy RC581-607
Accès en ligne:	https://doaj.org/article/0b95757e18124d97a8fecf549c4cabcb
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

PATTERN OF LOCAL IMMUNE ALTERATIONS IN THE PATIENTS WITH CHRONIC ADENOIDITIS, AND AN OPPORTUNITY OF THEIR CORRECTION WITH IMUNOFAN
par: R. N. Kuznetsova, et autres
Publié: (2014)

Prognostic value of severity indicators of nursing-home-acquired pneumonia versus community-acquired pneumonia in elderly patients
par: Ugajin M, et autres
Publié: (2014)

FEATURES OF IMMUNE DISTURBANCES IN COMMUNITY-ACQUIRED PNEUMONIAS
par: G. A. Mavziutova, et autres
Publié: (2014)

Characterization of the oxidative metabolism of erythrocytes in patients with community-acquired pneumonia
par: L. A. Demidchik, et autres
Publié: (2016)

Assessing the Impact of Gender and COPD on the Incidence and Mortality of Hospital-Acquired Pneumonia. A Retrospective Cohort Study Using the Spanish National Discharge Database (2016–2019)
par: Javier de-Miguel-Diez, et autres
Publié: (2021)

The COVID-19 Pandemic and the Incidence of the Non-COVID-19 Pneumonia in Adults
par: Chienhsiu Huang
Publié: (2021)

Clinical and laboratory findings in elderly with Community-Acquired Pneumonia in Babol, northern Iran – 2017-2019
par: Habibi Saleh, et autres
Publié: (2021)

Role of blood urea nitrogen and serum albumin ratio in predicting severity of community acquired pneumonia (CAP)
par: Mehul Agarwal, et autres
Publié: (2021)

Fluorocycline TP-271 Is Potent against Complicated Community-Acquired Bacterial Pneumonia Pathogens
par: Trudy H. Grossman, et autres
Publié: (2017)

Cell population data in identifying active tuberculosis and community-acquired pneumonia
par: Sun Tingting, et autres
Publié: (2021)

Evaluation of severity scoring systems in patients with severe community acquired pneumonia
par: Spasovska Katerina, et autres
Publié: (2021)

Associations of Serum Resistin With the Severity and Prognosis in Patients With Community-Acquired Pneumonia
par: Chun-Mei Feng, et autres
Publié: (2021)

Comparative effect of immunomodulators on the contents of hydrolase inhibitors and lactoferrin in community-acquired pneumonia in adults
par: M. P. Kostinov, et autres
Publié: (2020)

Declined Functional Status Prolonged Hospital Stay for Community-Acquired Pneumonia in Seniors
par: Chen H, et autres
Publié: (2020)

An Early Screening Tool for Discharge Planning Shortened Length of Hospital Stay for Elderly Patients with Community-Acquired Pneumonia
par: Chen H, et autres
Publié: (2021)

Association of Admission Blood Glucose Level with All-Cause Mortality According to Age in Patients with Community Acquired Pneumonia
par: Shen Y, et autres
Publié: (2021)

Community-Acquired Pneumonia among Patients with COPD in Spain from 2016 to 2019. Cohort Study Assessing Sex Differences in the Incidence and Outcomes Using Hospital Discharge Data
par: Javier de Miguel-Diez, et autres
Publié: (2021)

Clinical features of pneumonia with adverse outcome (based on materials of the therapeutic department of the Angapov Republican Clinical Emergency Hospital, Ulan-Ude for 2013-2015)
par: E. V. Bashkueva, et autres
Publié: (2017)

Community-Acquired Respiratory Distress Syndrome Toxin: Unique Exotoxin for M. pneumoniae
par: Xiaoling Su, et autres
Publié: (2021)

Mycoplasma Pneumoniae and Bronchial Asthma in Children
par: hala Elzawawy, et autres
Publié: (2020)

SPECTRUM OF CULTURE POSITIVE HOSPITAL ACQUIRED PNEUMONIA IN PATIENTS RECEIVING PROTON PUMP INHIBITORS
par: Aaqib Jahangir Khan, et autres
Publié: (2018)

The Performance of CURB-65 and PSI for Predicting In-Hospital Mortality of Community-Acquired Pneumonia in Patients with Type 2 Diabetes Compared with the Non-Diabetic Population
par: Ma CM, et autres
Publié: (2021)

Identified micro-organisms in hospitalized community-acquired pneumonia patients living near goat and poultry farms
par: Inge Roof, et autres
Publié: (2021)

In-hospital mortality associated with community-acquired pneumonia due to methicillin-resistant Staphylococcus aureus: a matched-pair cohort study
par: Yukiyo Sakamoto, et autres
Publié: (2021)

Method of quality improvement and economic efficiency of pharmacotherapy for community-acquired pneumonia and its utility in Ukraine health-care facilities
par: A.B. Zimenkovsky
Publié: (2020)

COMMUNITY-ACQUIRED PNEUMONIA PNEUMOCOCCAL ETIOLOGY AND MICROBIOLOGICAL ASPECTS OF NASOPHARYNGEAL CARRIAGE IN CHILDREN IN THE REPUBLIC OF TATARSTAN
par: L. T. Bayazitova, et autres
Publié: (2017)

Study on inflammatory factors and curative effect of Rhizoma Imperata on community acquired pneumonia based on TLR4/NF-κB signaling pathway
par: Qiu-Cheng Li, et autres
Publié: (2021)

Serum interleukin-17 predicts severity and prognosis in patients with community acquired pneumonia: a prospective cohort study
par: Chun-Mei Feng, et autres
Publié: (2021)

Age, Pulse, Urea and Albumin (APUA) Model: A Tool for Predicting in-Hospital Mortality of Community-Acquired Pneumonia Adapted for Patients with Type 2 Diabetes
par: Ma CM, et autres
Publié: (2020)

Fall of Community-Acquired Pneumonia in Children following COVID-19 Non-Pharmaceutical Interventions: A Time Series Analysis
par: Alexis Rybak, et autres
Publié: (2021)

IL-8 CHEMOTACTIC FACTOR IN PATIENTS WITH COMMUNITY-ACQUIRED PNEUMONIA AND FEATURES OF IL-8 GENE POLYMORPHISM (251 T/А)
par: L. F. Aznabaeva, et autres
Publié: (2014)

Prevención y tratamiento de la neumonía adquirida en la comunidad en pacientes adultos: Un enfoque para la atención primaria
par: FICA C.,ALBERTO
Publié: (2002)

Chlamydia pneumoniae-associated pleuropericarditis: a case report and systematic review of the literature
par: Konstantinos G. Kyriakoulis, et autres
Publié: (2021)

Diseño de un índice pronóstico clínico para el manejo de la neumonía del adulto adquirida en la comunidad
par: Saldías P,Fernando, et autres
Publié: (2004)

Amoxicillin duration and dose for community-acquired pneumonia in children: the CAP-IT factorial non-inferiority RCT
par: Sam Barratt, et autres
Publié: (2021)

Effect of adjunctive single high-dose vitamin D3 on outcome of community-acquired pneumonia in hospitalised adults: The VIDCAPS randomised controlled trial
par: Sandy Slow, et autres
Publié: (2018)

Características clínicas de la neumonía adquirida en la comunidad del adulto inmunocompetente hospitalizado según el agente causal
par: Saldias Peñafiel,Fernando, et autres
Publié: (2018)

Predictores clínicos de bacteriemia en adultos inmunocompetentes hospitalizados por neumonía adquirida en la comunidad
par: Saldías P,Fernando, et autres
Publié: (2015)

An unusual non-resolving community-acquired pneumonia
par: Andrea Zappalà, et autres
Publié: (2021)

Сlinical case of focal alopecia in a child with atopy
par: A. A. Barilo, et autres
Publié: (2021)